NATCO Pharma Statistics

Total Valuation

NATCO Pharma has a market cap or net worth of INR 161.96 billion. The enterprise value is 139.84 billion.

Market Cap	161.96B
Enterprise Value	139.84B

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	Aug 19, 2025

Share Statistics

NATCO Pharma has 179.11 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	179.11M
Shares Outstanding	179.11M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	30.70%
Owned by Institutions (%)	13.28%
Float	81.33M

Valuation Ratios

The trailing PE ratio is 9.54 and the forward PE ratio is 15.36.

PE Ratio	9.54
Forward PE	15.36
PS Ratio	3.68
PB Ratio	2.13
P/TBV Ratio	2.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	8.24
EV / Sales	3.18
EV / EBITDA	7.13
EV / EBIT	8.16
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	0.14
Debt / FCF	n/a
Interest Coverage	78.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	15.17%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	10.95M
Profits Per Employee	4.23M
Employee Count	4,016
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NATCO Pharma has paid 3.65 billion in taxes.

Income Tax	3.65B
Effective Tax Rate	17.70%

Stock Price Statistics

The stock price has decreased by -40.29% in the last 52 weeks. The beta is 0.19, so NATCO Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	-40.29%
50-Day Moving Average	938.48
200-Day Moving Average	1,052.51
Relative Strength Index (RSI)	37.87
Average Volume (20 Days)	898,563

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NATCO Pharma had revenue of INR 43.96 billion and earned 16.98 billion in profits. Earnings per share was 94.78.

Revenue	43.96B
Gross Profit	36.53B
Operating Income	17.14B
Pretax Income	20.60B
Net Income	16.98B
EBITDA	19.63B
EBIT	17.14B
Earnings Per Share (EPS)	94.78

Full Income Statement

Balance Sheet

The company has 24.97 billion in cash and 2.79 billion in debt, giving a net cash position of 22.17 billion or 123.80 per share.

Cash & Cash Equivalents	24.97B
Total Debt	2.79B
Net Cash	22.17B
Net Cash Per Share	123.80
Equity (Book Value)	76.12B
Book Value Per Share	424.69
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 83.11%, with operating and profit margins of 38.98% and 38.62%.

Gross Margin	83.11%
Operating Margin	38.98%
Pretax Margin	46.86%
Profit Margin	38.62%
EBITDA Margin	44.64%
EBIT Margin	38.98%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.66%.

Dividend Per Share	6.00
Dividend Yield	0.66%
Dividend Growth (YoY)	-36.84%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	0.68%
Earnings Yield	10.48%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 26, 2015. It was a forward split with a ratio of 5.

Last Split Date	Nov 26, 2015
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1